OpGen Presents Preliminary Acuitas® AMR Gene Panel Data for Detecting Urinary Tract Infections
07. Oktober 2019 07:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., Oct. 07, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) today announced the presentation of preliminary data at IDWeek 2019 for the Company’s Acuitas® AMR Gene Panel and...
OpGen Provides update on Curetis Group’s R&D Collaboration
18. September 2019 07:30 ET
|
OpGen, Inc.
Curetis R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdbCollaborator to fund R&D and obtains option to license ARESdb and ARES Technology...
OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress
08. September 2016 07:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., Sept. 08, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will participate in the World Anti-Microbial Resistance Congress being held September 8-9 in...
The Joint Commission Enterprise Launches HAI Portal
02. April 2012 23:15 ET
|
The Joint Commission
OAKBROOK TERRACE, IL--(Marketwire - Apr 2, 2012) - Today, The Joint Commission enterprise launched a health care-associated infections (HAI) electronic portal that provides a wealth of HAI...